FLECTOR Drug Patent Profile

When do Flector patents expire, and when can generic versions of Flector launch?

Flector is a drug marketed by Ibsa and is included in one NDA.

The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.

Summary for FLECTOR

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	25
Clinical Trials:	5
Patent Applications:	103
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for FLECTOR
What excipients (inactive ingredients) are in FLECTOR?	FLECTOR excipients list
DailyMed Link:	FLECTOR at DailyMed

See drug prices for FLECTOR

See drug sales revenues for FLECTOR

Recent Clinical Trials for FLECTOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Fidia Farmaceutici s.p.a.	Phase 3
Fidia Farmaceutici s.p.a.	Phase 1
Actavis Inc.	Phase 3

See all FLECTOR clinical trials

Pharmacology for FLECTOR

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors
Physiological Effect	Decreased Prostaglandin Production

Anatomical Therapeutic Chemical (ATC) Classes for FLECTOR

D11AX	Other dermatologicals
D11A	OTHER DERMATOLOGICAL PREPARATIONS
D11	OTHER DERMATOLOGICAL PREPARATIONS
D	Dermatologicals

M01AB	Acetic acid derivatives and related substances
M01A	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

M02AA	Antiinflammatory preparations, non-steroids for topical use
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

S01BC	Antiinflammatory agents, non-steroids
S01B	ANTIINFLAMMATORY AGENTS
S01	OPHTHALMOLOGICALS
S	Sensory organs

Paragraph IV (Patent) Challenges for FLECTOR

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
FLECTOR	Topical Patch	diclofenac epolamine	1.3%	021234	1	2015-06-26

US Patents and Regulatory Information for FLECTOR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007		RX	Yes	Yes

Expired US Patents for FLECTOR

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007
Ibsa	FLECTOR	diclofenac epolamine	SYSTEM;TOPICAL	021234-001	Jan 31, 2007

International Patents for FLECTOR

See the table below for patents covering FLECTOR around the world.

Country	Patent Number	Title	Estimated Expiration
Japan	H06305958	PLASTER ANTIPHLOGISTIC ANALGESIC PLASTER FOR EXTERNAL USE
Canada	1303050	SEL DE DICLOFENAC ET D'UNE BASE ORGANIQUE CYCLIQUE, ET COMPOSITIONS PHARMACEUTIQUES QUI EN CONTIENNENT (SALT OF DICLOFENAC WITH A CYCLIC ORGANIC BASE AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN IT)
Greece	3034616
Spain	2029254